Table 2.
Controls → CH patients | CH patients → Cirrhotic patients | |||||
---|---|---|---|---|---|---|
AUROC curve | 95% CI | P | AUROC curve | 95% CI | P | |
Total HSA (g/dl) | 0.800 | 0.657–0.943 | 0.002 | 0.898 | 0.832–0.963 | 0.000 |
Oxidized/total HSA | 0.722 | 0.551–0.892 | 0.024 | 0.894 | 0.820–0.969 | 0.000 |
Oxidized HSA (g/dl) | 0.598 | 0.406–0.791 | 0.316 | 0.51 | 0.423–0.659 | 0.567 |
Reduced HSA (g/dl) | 0.903 | 0.807–0.999 | 0.000 | 0.931 | 0.875–0.987 | 0.000 |
P < 0.05 was considered to indicate a statistically significant difference
CH chronic hepatitis, CI confidential interval, HSA human serum albumin